Potential adverse effects of SGLT2i in horses

Bruce C McGorum, John A Keen, Sophie McCullagh, Celia M Marr, Catriona MacKenzie, Harry Carslake, Nicola Menzies-Gow, Bettina Dunkel, Mike Hewetson, Jennifer Reed, Edd Knowles

Research output: Contribution to journalLetter

Abstract

WE write to raise awareness of potential adverse effects of sodium-glucose cotransporter 2 inhibitors (SGLT2i), which are increasingly being used in the treatment of horses with equine metabolic syndrome (EMS), refractory hyperinsulinaemia and associated laminitis.
Original languageEnglish
Pages (from-to)253-254
Number of pages2
JournalVeterinary Record
Volume195
Issue number6
DOIs
Publication statusE-pub ahead of print - 20 Sept 2024

Fingerprint

Dive into the research topics of 'Potential adverse effects of SGLT2i in horses'. Together they form a unique fingerprint.

Cite this